PIRIBEDIL THERAPY IN PARKINSONS-DISEASE - USE OF THE DRUG IN THE RETARD FORM

被引：24

作者：

MENTENOPOULOS, G ^{[1
]}

KATSAROU, Z ^{[1
]}

BOSTANTJOPOULOU, S ^{[1
]}

LOGOTHETIS, J ^{[1
]}

机构：

[1] ARISTOTELIAN UNIV SALONIKA, AHEPA HOSP, DEPT NEUROL 2, SALONIKA, GREECE

来源：

CLINICAL NEUROPHARMACOLOGY | 1989年 / 12卷 / 01期

关键词：

D O I：

10.1097/00002826-198902000-00003

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：23 / 28

页数：6

共 15 条

[1] AN INVENTORY FOR MEASURING DEPRESSION [J].

BECK, AT ;

ERBAUGH, J ;

WARD, CH ;

MOCK, J ;

MENDELSOHN, M .

ARCHIVES OF GENERAL PSYCHIATRY, 1961, 4 (06) :561-&

[2] PIRIBEDIL (ET-495) IN TREATMENT OF PARKINSONS-DISEASE COMBINED WITH AMANTADINE OR LEVODOPA [J].

CALLAGHAN, N ;

FITZPATRICK, E ;

OMAHONY, JB .

ACTA NEUROLOGICA SCANDINAVICA, 1975, 52 (03) :179-186

[3]

Chase T N, 1974, Adv Biochem Psychopharmacol, V12, P427

[4] CENTRAL MONOAMINE METABOLISM IN MAN - EFFECT OF PUTATIVE DOPAMINE RECEPTOR AGONISTS AND ANTAGONISTS [J].

CHASE, TN .

ARCHIVES OF NEUROLOGY, 1973, 29 (05) :349-351

[5] EVIDENCE FOR A NEW TYPE OF DOPAMINE RECEPTOR STIMULATING AGENT [J].

CORRODI, H ;

UNGERSTEDT, U .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1971, 23 (12) :989-+

[6]

GUILLARD A, 1983, ENCY MED CHIR PARIS, V3, P1

[7] PARKINSONISM - ONSET PROGRESSION AND MORTALITY [J].

HOEHN, MM ;

YAHR, MD .

NEUROLOGY, 1967, 17 (05) :427-&

[8]

LIEBERMAN AN, 1986, CLIN NEUROPHARMACOL, V9, pS9

[9]

MCDOWELL FH, 1975, DOPAMINERGIC MECHANI, V9, P367

[10]

MCLELLAN DL, 1975, ACTA NEUROL SCAND, V51, P74

← 1 2 →